Genetics, molecular mechanisms and management of long QT syndrome.
- 1 January 1998
- journal article
- review article
- Published by Informa UK Limited in Annals of Medicine
- Vol. 30 (1), 58-65
- https://doi.org/10.3109/07853899808999385
Abstract
Cardiac arrhythmias cause more than 300 000 sudden deaths each year in the USA alone. Long QT syndrome (LQT) is a cardiac disorder that causes sudden death from ventricular tachyarrhythmias, specifically torsade de pointes. Four LQT genes have been identified: KVLQT1 (LQT1) on chromosome llpl5.5, HERG (LQT2) on chromosome 7q35–36, SCNSA (LQT3) on chromosome 3p21–24, and MinK (LQT5) on chromosome 21q22. SCNSA encodes the cardiac sodium channel, and LQT-causing mutations in SCNSA lead to the generation of a late phase of inactivation-resistant whole-cell inward currents. Mexiletine, a sodium channel blocker, is effective in shortening the QT interval corrected for heart rate (QTc) of patients with SCNSA mutations. HERG encodes the cardiac I potassium channel. Mutations in HERG act by a dominant-negative mechanism or by a loss-of-function mechanism. Raising the serum potassium concentration can increase outward HERG potassium current and is effective in shortening the QTc of patients with HERG mutations. KVLQT1 is a cardiac potassium channel protein that interacts with another small potassium channel MinK to form the cardiac I potassium channel. Like HERG mutations, mutations in KVLQT1 and MinK can act by a dominant-negative mechanism or a loss-of-function mechanism. An effective treatment for LQT patients with KVLQT1 or MinK mutations is expected to be developed based on the functional characterization of the IKs potassium channel. Genetic testing is now available for some patients with LQT.Keywords
This publication has 50 references indexed in Scilit:
- Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmiaHuman Molecular Genetics, 1995
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- The long QT syndrome. Prospective longitudinal study of 328 families.Circulation, 1991
- Linkage of a Cardiac Arrhythmia, the Long QT Syndrome, and the Harvey ras -1 GeneScience, 1991
- Proarrhythmic effects of antiarrhythmic drugsThe American Journal of Cardiology, 1987
- Ventricular Tachyarrhythmias in the Long QT SyndromesMedical Clinics of North America, 1984
- The long Q-T syndromeAmerican Heart Journal, 1975
- CONGENITAL CARDIAC ARRHYTHMIAThe Lancet, 1965
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathAmerican Heart Journal, 1957